Grufity logo
Grufity logo
FBRX

FBRX - Forte Biosciences, Inc. Stock Price, Fair Value and News

$76.99 
Delayed as of 28 Aug 2026, 04:00 pm ET

FBRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FBRX Price Action

Last 7 days

0.1%

Last 30 days

0.6%

Last 90 days

303.7%

Trailing 12 Months

585.6%

FBRX RSI Chart

FBRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FBRX Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-17.93

Price/Sales (Trailing)

43.7K

EV/EBITDA

-23.57

Price/Free Cashflow

-21.89

FBRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

FBRX Fundamentals

FBRX Revenue

Revenue (TTM)

36.0K

FBRX Earnings

Earnings (TTM)

-87.9M

Earnings Growth (Yr)

-107.41%

Earnings Growth (Qtr)

-5.4%

FBRX Profitability

EBT Margin

-189827.78%

Return on Equity

-47.85%

Return on Assets

-42.74%

Free Cashflow Yield

-4.57%

FBRX Investor Care

Shares Dilution (1Y)

66.77%

Diluted EPS (TTM)

-4.62

Revenue & Growth

How Forte Biosciences, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
201913.5M9.0M4.5M36.0K
201839.0K9.0M-18.0M
201753.5K58.0K62.5K67.0K
2016106.8K87.5K68.3K49.0K
2015---126.0K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Forte Biosciences, Inc.

FBRX
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
 CEO
 WEBSITEfortebiorx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES7

Forte Biosciences, Inc. Frequently Asked Questions

FBRX is the stock ticker symbol of Forte Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Aug 28 2026, market cap of Forte Biosciences, Inc. is 1.58 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Aug 28 2026, FBRX's PE ratio (Price to Earnings) is -17.93 and Price to Sales (PS) ratio is 43.69 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FBRX PE ratio will change depending on the future growth rate expectations of investors.